Difference between revisions of "CD10"

From Libre Pathology
Jump to navigation Jump to search
Line 14: Line 14:
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal  | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref>
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal  | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref>
*[[Endometrial stromal sarcoma]].
*[[Endometrial stromal sarcoma]].
*[[Solid and pseudopapillary tumour]].
*[[Solid pseudopapillary tumour]].


==See also==
==See also==

Revision as of 17:45, 20 March 2015

CD10 is a commonly used immunostain.

Positive

Benign

Lymphoma

Other tumours

See also

References

  1. 1.0 1.1 Lin, F.; Abdallah, H.; Meschter, S. (Feb 2004). "Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.". Diagn Cytopathol 30 (2): 92-7. doi:10.1002/dc.10419. PMID 14755758.
  2. Tadrous, Paul.J. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum (1st ed.). Wiley. pp. 236. ISBN 978-0470519035.